combination therapy with glp-1 receptor agonist and sglt2 inhibitor Blood pressure effects of inhibitors GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology Illustration of potential synergistic effects
Description
Profound cognitive and behavioral issues need to be analyzed according to a sound patient-centred methodology and integrated with lifestyle and pharmaceutical tools
GLP-1s have demonstrated anti-fibrotic properties in other organs (liver, kidney, heart) by reducing collagen deposition and tissue scarring (10)
Am J Physiol Gastrointest Liver Physiol
Jastreboff 2023
Importantly, to evaluate adverse or compensatory effects, a GIP receptor antagonist must be administered longer than those presented so far
doi: 10.1016/j.metabol.2019.154045
